Response to infliximab is related to disease duration in paediatric Crohn's disease
Paolo Lionetti(Meyer Children's Hospital), A. Barabino(Istituto Giannina Gaslini), C. Bascietto(Sapienza University of Rome), Roberto Berni Canani(Federico II University Hospital), Graziella Guariso(University of Padua), Camilla Salvestrini(Meyer Children's Hospital), F. Bronzini(Meyer Children's Hospital), Stefano Martelossi(IRCCS Materno Infantile Burlo Garofolo), Gian Luigi De’ Angelis(University of Parma), B. Papadatou(Bambino Gesù Children's Hospital)
Cited by 145
Related Papers
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
|Proceedings of the National Academy of Sciences|2010|5.6k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Management of Pediatric Ulcerative Colitis
|Journal of Pediatric Gastroenterology and Nutrition|2012|377
Management Guidelines of Eosinophilic Esophagitis in Childhood
|Journal of Pediatric Gastroenterology and Nutrition|2013|341